Funding for gambling addiction research and treatment is fraught with challenges, a reality that starkly contrasts with what many might expect. A notable example is a Twitter critic who shifted their stance on this issue. Initially, they argued that the gambling industry should contribute to research and treatment. Just a week later, they insisted that the industry should be barred from engaging with funding for these very initiatives. This inconsistency highlights the need for logical, rather than emotional, discussions surrounding such topics.
In 2026, it’s clear that separating a donation from its intended objective is quite straightforward. For instance, a contribution can be directed toward a specific study on gambling addiction within the disabled population. Once the funds are provided, the donating entity typically remains uninvolved as the research unfolds, which may take several years for results to materialize.
There is little justification for believing that the gambling industry would seek to manipulate such research outcomes. In fact, one of the key reasons for industry involvement in both research and treatment is the wealth of data it possesses. Critics might argue that the industry bears some responsibility for the challenges faced by affected players, especially when considering instances of ignoring self-exclusion requests or targeting players who have opted out. If that is indeed the case, it makes sense for the industry to engage in efforts to understand and address these issues.
Currently, funding for gambling addiction treatment is limited and often grouped with other types of addiction treatments, even though their treatment methodologies can differ significantly. While drug abuse may contribute to gambling addiction, the two issues do not necessitate the same therapeutic approaches.
The industry should contribute to both treatment and research across countries with legal gambling markets. While funding for research could be beneficial, sharing anonymized data with researchers can be just as impactful. More comprehensive access to quality data is paramount for advancing research agendas and, in doing so, improving the industry's approach to gambling addiction.
Notably, not every source of funding is created equal. Organizations like the National Council on Problem Gambling (NCPG) in the U.S. are engaged in critical work, especially as the country grapples with the aftermath of legalizing sports betting post-PASPA. The absence of a federal framework has resulted in individual states developing their own, often flawed, solutions to addiction related issues.
Despite its importance, trust has recently been jeopardized as the Michigan Gaming Control Board (MGCB) and the Nevada Council on Problem Gambling (NVCPG) withdrew from the NCPG. This occurred following the controversial funding received from Kalshi, a company involved in prediction markets. Many regulators and problem gambling organizations view these markets with skepticism, advocating that they should fall under gambling regulations rather than being overseen by a federal body lacking gambling expertise.
The NCPG's acceptance of a $2 million grant from Kalshi for a new initiative on trader health raises questions about trust and decision-making within the organization. The funding represents a modest sum for a company experiencing explosive growth, yet what concerns many is the perception of influence such contributions can engender in political and regulatory circles.
Kalshi’s assertive stance against being labeled as a gambling entity contradicts the very basis on which the NCPG created a new membership category for financial services and trading, suggesting it could be prudent for Kalshi to reconsider its classification. If it looks, talks, and behaves like gambling, it raises inevitable concerns about their role in the wider discourse on gambling regulation and treatment.
